Anatomic Pathology Market Size Worth $65.54 Billion By 2030 | CAGR: 7.3%, Increase in chronic disease cases and a need to address the quick diagnosis of medical disorders fueling the global market

Global anatomic pathology market was valued at USD 35.21 billion in 2021 and is expected to reach USD 65.54 Billion By 2030, growing at a CAGR of 7.3% during the forecast period.

The global industry is expected to increase rapidly due to the growing focus on customized care and a large number of supporting programs and training modules provided by the government. The geriatric population is rapidly growing, as is the incidence rate of cancer and other chronic disorders. The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Modern anatomic pathology technology is becoming more widely used because of the significant rise in cancer cases.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/anatomic-pathology-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Top Market Players Are:

Agilent Technologies, Abcam plc, Amos Scientific Pty Ltd., Bio SB, BioGenex, Bright Instruments, Cell Signaling Technology, Inc., Beckton, CellPath Ltd., Danaher Corporation, Diapath S.p.A, Dickson and Company, Cardinal Health, F. Hoffmann-La Roche AG, Hologic, Inc., Jinhua Yidi Medical Equipment Co., Ltd., Histo-Line Laboratories, Laboratory Corporation of America Holdings, Lupetec, Medimeas, Merck KGaA, MICROS AUSTRIA, Milestone Medical, NeoGenomics Laboratories, Inc., MEDITE Medical GmbH, Quest Diagnostics Incorporated, R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED, PHC Holdings Corporation, Sakura Finetek, and SLEE medical GmbH are some of the major players in the market.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/12291

The industry is being driven by an increase in chronic disease cases and a need to address the quick diagnosis of medical disorders. Because the elderly are more susceptible to numerous illnesses, this demographic trend is expected to significantly increase the prevalence of several chronic diseases, including cancer, worldwide.

Furthermore, rising awareness and increased patient pool in developing countries propel the industry forward. Additionally, the industry is being driven by an increase in healthcare expenditure and the use of biomarkers during illness diagnosis.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/anatomic-pathology-market/inquire-before-buying

(Inquire a report quote OR available discount offers to the sales team before purchase.)

Over the projected period, the drug discovery and development segment is expected to increase at a profitable rate. During preclinical studies, pathologists' tissue analysis provides pharmaceutical companies with a wide range of information. Moreover, the biologic's manufacturing service is also expected to register significant growth in the overall industry. This is due to the robust pipeline of new biological drugs due to the growing commercial success of biopharma companies across developed and developing economies paving the segment's growth.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/anatomic-pathology-market

In December 2021, Quest Diagnostics Incorporated introduced the liquid biopsy-based Target Selector NGS Lung Panel test. In October 2021, Roche partnered with PathAI, a global leader in artificial intelligence (AI)-based technologies. The firms will collaborate on pathologists' embedded image analysis workflow as part of the development and distribution arrangement.

Polaris Market Research has segmented the anatomic pathology market report based on product, application, end-use, and region:

Anatomic Pathology, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Instruments
Microtomes & Cryostat
Tissue Processors
Automatic Stainers
Whole Slide Imaging (WSI) Scanners
Other Products
Consumables
Reagents & Antibodies
Probes & Kits
Others
Services

Anatomic Pathology, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Disease Diagnosis
Drug Discovery and Development
Others

Anatomic Pathology, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals
Research Laboratories
Diagnostic Laboratories
Others

Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Ph: +1-929 297-9727

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

This release was published on openPR.